In this episode, we explore Multiple Myeloma, a rare and complex blood cancer, with insights from experts and a patient navigating the journey firsthand. Together, they share the challenges of diagnosis, advancements in treatment, and hope through innovative care.

• Ron Theissen – A patient sharing his courageous story of resilience.
• Dr. Joseph Maakaron – A leading oncologist, Assistant Professor of Medicine at the University of Minnesota, and Clinical Investigator in the Bone Marrow Transplant Division and Stem Cell Institute.
• Jeff Liter – CEO of Luminary Therapeutics, a clinical-stage company transforming care with allogeneic cellular therapies.

This conversation highlights the strength of the Multiple Myeloma community and the transformative impact of cutting-edge research and personalized care.

#MultipleMyeloma #BloodCancerAwareness #PatientInnovations #HealthcareAdvances

Additional Resources:

• The MMRF | Multiple Myeloma Research Foundation
• Leukemia & Lymphoma Society | Blood Cancer Leaders | LLS
• Lymphoma Research Foundation | Research. Community. Cure